相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nodal Downstaging of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy: Survival Analysis if ypN0 Is Achieved
Han Tang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2020)
Endoscopic ultrasound and fine-needle aspiration for the detection of residual nodal disease after neoadjuvant chemoradiotherapy for esophageal cancer
Ruben D. van der Bogt et al.
ENDOSCOPY (2020)
Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2
Yuko Kitagawa et al.
ESOPHAGUS (2019)
Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1
Yuko Kitagawa et al.
ESOPHAGUS (2019)
PD-L1 expression, CD8+and CD4+lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus
Matteo Fassan et al.
CANCER MEDICINE (2019)
Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
Aurelie Hanoteau et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial
Bo Jan Noordman et al.
BMC CANCER (2018)
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study
Bo Jan Noordman et al.
LANCET ONCOLOGY (2018)
ypT0N+: the unusual patient with pathological complete tumor response but with residual lymph node disease after neoadjuvant chemoradiation for esophageal cancer, what's up?
Lieven Peter Depypere et al.
JOURNAL OF THORACIC DISEASE (2018)
Neoadjuvant chemoradiotherapy followed by minimally invasive esophagectomy: is it a superior approach for locally advanced resectable esophageal squamous cell carcinoma?
Han Tang et al.
JOURNAL OF THORACIC DISEASE (2018)
Integrated genomic characterization of oesophageal carcinoma
Jihun Kim et al.
NATURE (2017)
CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT3-4aN0-1M0) (NCT03001596)
Han Tang et al.
BMC CANCER (2017)
Characterization of residual tumours at the primary site in patients with a near pathological complete response after neoadjuvant chemoradiotherapy for oesophageal cancer
Y. -K. Chao et al.
BRITISH JOURNAL OF SURGERY (2016)
Endoscopic biopsy and EUS for the detection of pathologic complete response after neoadjuvant chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis
Peter S. N. van Rossum et al.
GASTROINTESTINAL ENDOSCOPY (2016)
A study about different findings of PET-CT between neoadjuvant and non-neoadjuvant therapy: SUVmax is not a reliable predictor of lymphatic involvement after neoadjuvant therapy for esophageal cancer
Jae Kil Park et al.
JOURNAL OF THORACIC DISEASE (2016)
The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response
Aaron U. Blackham et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Outcomes, quality of life, and survival after esophagectomy for squamous cell carcinoma: A propensity score-matched comparison of operative approaches
Hao Wang et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2015)
Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers
K. Kumagai et al.
BRITISH JOURNAL OF SURGERY (2014)
Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901
Christophe Mariette et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Identification of genomic alterations in oesophageal squamous cell cancer
Yongmei Song et al.
NATURE (2014)
Genetic landscape of esophageal squamous cell carcinoma
Yi-Bo Gao et al.
NATURE GENETICS (2014)
Residual Esophageal Cancer after Neoadjuvant Chemoradiotherapy Frequently Involves the Mucosa and Submucosa
Joel Shapiro et al.
ANNALS OF SURGERY (2013)
Three-arm Phase III Trial Comparing Cisplatin Plus 5-FU (CF) Versus Docetaxel, Cisplatin Plus 5-FU (DCF) Versus Radiotherapy with CF (CF-RT) as Preoperative Therapy for Locally Advanced Esophageal Cancer (JCOG1109, NExT Study)
Kenichi Nakamura et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2013)
A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
Nobutoshi Ando et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial
Surya S. A. Y. Biere et al.
LANCET (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Pathologic T0N1 Esophageal Cancer After Neoadjuvant Therapy and Surgery: An Orphan Status
Min P. Kim et al.
ANNALS OF THORACIC SURGERY (2010)
Pathological Analysis After Neoadjuvant Chemoradiotherapy for Esophageal Carcinoma: The Rotterdam Experience
E. Van Meerten et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation
LR Chirieac et al.
CANCER (2005)
Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome
J Shia et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
分享论文
